Kimball AB, Jemec GBE, Sayed CJ, Kirby JS, Prens E, Ingram JR, Garg A, Gottlieb AB, Szepietowski JC, Bechara FG, et al. Bimekizumab efficacy and safety in patients with moderate to severe hidradenitis suppurativa: two 48 week, randomised, double blind, placebo controlled, multicentre phase 3 trials (BE HEARD I and II). Lancet. 2024
Hayama K, Tian Y, Iwasaki R, Fujita H. Patient Journey of Generalized Pustular Psoriasis: A Real-World Study Using Data Mining Methods and Japanese Claims Data. Acta Dermato-Venereologica. 2024
Fujita H, Iwasaki R, Tsuboi S, Murashima Y, Akiyama M. Regional differences in the prevalence of generalized pustular psoriasis in Japan. Journal of Dermatology. 2024
Ikumi N, Ngasawa Y, Nakamura H, Fujita H. Radiological improvement of peripheral arthritis in a patient with psoriatic arthritis treated with deucravacitinib. 2024
Hayama K, Iwasaki R, Tian Y, Fujita H. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study. Journal of Dermatology. 2023. 50. 1531-1538
Nakao M, Sugaya M, Fujita H, Miyagaki T, Morimura S, Shibata S, Asano Y, Sato S. TLR2 deficiency exacerbates imiquimod-induced psoriasis-like skin inflammation through decrease in regulatory T cells and impaired IL-10 production. International Journal of Molecular Sciences. 2020. 21. 22. 8560
